Skip to Main Content

Author Details

Dalia Barsyte-Lovejoy
University of Toronto, College St
1999
108
45
PMIDPaper TitleJournal TitlePublished Year
38072134Epigenetic vulnerabilities of leukemia harboring inactivating EZH2 mutations.Exp Hematol2024
36802665Discovery and Characterization of BAY-805, a Potent and Selective Inhibitor of Ubiquitin-Specific Protease USP21.J Med Chem2023
37961297Recruitment of FBXO22 for Targeted Degradation of NSD2.bioRxiv2023
37558947HiBiT Cellular Thermal Shift Assay (HiBiT CETSA).Methods Mol Biol2023
37558946Measuring Protein-Protein Interactions in Cells using Nanoluciferase Bioluminescence Resonance Energy Transfer (NanoBRET) Assay.Methods Mol Biol2023
37770003Development of LM-41 and AF-2112, two flufenamic acid-derived TEAD inhibitors obtained through the replacement of the trifluoromethyl group by aryl rings.Bioorg Med Chem Lett2023
37602846Studying Protein Arginine Methylation: Approaches and Methods.J Vis Exp2023
36948210Discovery of Nanomolar DCAF1 Small Molecule Ligands.J Med Chem2023
36976643Discovery of a Potent and Selective Targeted NSD2 Degrader for the Reduction of H3K36me2.J Am Chem Soc2023
36914634Reference compounds for characterizing cellular injury in high-content cellular morphology assays.Nat Commun2023
34782742A chemical probe targeting the PWWP domain alters NSD2 nucleolar localization.Nat Chem Biol2022
35578032PRMT inhibition induces a viral mimicry response in triple-negative breast cancer.Nat Chem Biol2022
35363509Validating Small Molecule Chemical Probes for Biological Discovery.Annu Rev Biochem2022
35753676Chemical biology and pharmacology of histone lysine methylation inhibitors.Biochim Biophys Acta Gene Regul Mech2022
36467544Distal extracellular teneurin region (teneurin C-terminal associated peptide; TCAP) possesses independent intracellular calcium regulating actions, <i>in vitro</i>: A potential antagonist of corticotropin-releasing factor (CRF).Biochem Biophys Rep2022
36523555Skeletal muscle metabolism and contraction performance regulation by teneurin C-terminal-associated peptide-1.Front Physiol2022
35907431Enzymatic nucleosome acetylation selectively affects activity of histone methyltransferases in vitro.Biochim Biophys Acta Gene Regul Mech2022
36084291Combinatorial Anticancer Drug Screen Identifies Off-Target Effects of Epigenetic Chemical Probes.ACS Chem Biol2022
34164919Development of LM98, a Small-Molecule TEAD Inhibitor Derived from Flufenamic Acid.ChemMedChem2021
33522809Discovery of Small-Molecule Antagonists of the PWWP Domain of NSD2.J Med Chem2021
33742187Protein arginine methylation: from enigmatic functions to therapeutic targeting.Nat Rev Drug Discov2021
33513288Rational Design and Synthesis of Selective PRMT4 Inhibitors: A New Chemotype for Development of Cancer Therapeutics*.ChemMedChem2021
33591753A First-in-Class, Highly Selective and Cell-Active Allosteric Inhibitor of Protein Arginine Methyltransferase 6.J Med Chem2021
33579912PRMT5 inhibition disrupts splicing and stemness in glioblastoma.Nat Commun2021
34440512Structure and Function of Protein Arginine Methyltransferase PRMT7.Life (Basel)2021
34424246Quantitative Methods to Study Protein Arginine Methyltransferase 1-9 Activity in Cells.J Vis Exp2021
34154424Discovery of the SMYD3 Inhibitor BAY-6035 Using Thermal Shift Assay (TSA)-Based High-Throughput Screening.SLAS Discov2021
33980013Design, Synthesis, and Evaluation of WD-Repeat-Containing Protein 5 (WDR5) Degraders.J Med Chem2021
32367723Discovery of a First-in-Class Protein Arginine Methyltransferase 6 (PRMT6) Covalent Inhibitor.J Med Chem2020
33054974Correction: A chemical probe of CARM1 alters epigenetic plasticity against breast cancer cell invasion.Elife2020
32409666Pharmacological inhibition of PRMT7 links arginine monomethylation to the cellular stress response.Nat Commun2020
32297856Telomere dysfunction cooperates with epigenetic alterations to impair murine embryonic stem cell fate commitment.Elife2020
32457299Author Correction: Pharmacological inhibition of PRMT7 links arginine monomethylation to the cellular stress response.Nat Commun2020
30352278Characterization of inv(3) cell line OCI-AML-20 with stroma-dependent CD34 expression.Exp Hematol2019
31781029Synthetic Peptides as Therapeutic Agents: Lessons Learned From Evolutionary Ancient Peptides and Their Transit Across Blood-Brain Barriers.Front Endocrinol (Lausanne)2019
31657716A chemical probe of CARM1 alters epigenetic plasticity against breast cancer cell invasion.Elife2019
31848333Discovery of a chemical probe for PRDM9.Nat Commun2019
31559307SETD7 at the heart of chromatin factor interplay.Stem Cell Investig2019
31415173Selective, Small-Molecule Co-Factor Binding Site Inhibition of a Su(var)3-9, Enhancer of Zeste, Trithorax Domain Containing Lysine Methyltransferase.J Med Chem2019
31408619Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation.Cancer Cell2019
31287992A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain Tumor.Cancer Cell2019
31260300Discovery of a Potent and Selective Fragment-like Inhibitor of Methyllysine Reader Protein Spindlin 1 (SPIN1).J Med Chem2019
31285596Fragment-based discovery of a chemical probe for the PWWP1 domain of NSD3.Nat Chem Biol2019
30926792Targeting bivalency de-represses Indian Hedgehog and inhibits self-renewal of colorectal cancer-initiating cells.Nat Commun2019
30774623Teneurin C-Terminal Associated Peptide (TCAP)-1 and Latrophilin Interaction in HEK293 Cells: Evidence for Modulation of Intercellular Adhesion.Front Endocrinol (Lausanne)2019
31104094Targeting protein methylation: from chemical tools to precision medicines.Cell Mol Life Sci2019
30462309Direct interaction between the PRDM3 and PRDM16 tumor suppressors and the NuRD chromatin remodeling complex.Nucleic Acids Res2019
29244490Discovery of Potent and Selective Allosteric Inhibitors of Protein Arginine Methyltransferase 3 (PRMT3).J Med Chem2018
30034588LLY-283, a Potent and Selective Inhibitor of Arginine Methyltransferase 5, PRMT5, with Antitumor Activity.ACS Med Chem Lett2018
29921600Mammary molecular portraits reveal lineage-specific features and progenitor cell vulnerabilities.J Cell Biol2018
  • 1 - 50 of 108

Recommended Authors

Duke University School of Medicine Durham
Career Start Year 2013
Number of shared co-authors 1
Washington University School of Medicine
Career Start Year 2012
Number of shared co-authors 4
Johns Hopkins School of Medicine
Career Start Year 2008
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 1
National Cancer Institute, National Institutes of Health
Career Start Year 2005
Number of shared co-authors 2
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Career Start Year 2003
Number of shared co-authors 12
Virginia Commonwealth University
Career Start Year 2001
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 2000
Number of shared co-authors 1
Clinical Research Division, Fred Hutchinson Cancer Center
Career Start Year 2000
Number of shared co-authors 1
Institute of Hematology, West China Hospital of Sichuan University
Career Start Year 1999
Number of shared co-authors 8
Memorial Sloan-Kettering Cancer Center
Career Start Year 1998
Number of shared co-authors 1
Friedrich Miescher Institute for Biomedical Research
Career Start Year 1997
Number of shared co-authors 0
Genomics Institute of the Novartis Research Foundation
Career Start Year 1995
Number of shared co-authors 0
Sirna Therapeutics a former subsidiary of Merck & Co., Inc.
Career Start Year 1994
Number of shared co-authors 0
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 1994
Number of shared co-authors 1
Medicines Research Centre
Career Start Year 1994
Number of shared co-authors 10
Stanford University
Career Start Year 1994
Number of shared co-authors 6
Broad Institute of Harvard and MIT
Career Start Year 1993
Number of shared co-authors 7
College of Animal Medicine, Xinjiang Agricultural University
Career Start Year 1992
Number of shared co-authors 2
St. George's University Medical School
Career Start Year 1990
Number of shared co-authors 4
Broad Institute of Harvard and MIT
Career Start Year 1990
Number of shared co-authors 4
Brigham and Women's Hospital, Blavatnik Institute, Harvard Medical School
Career Start Year 1990
Number of shared co-authors 2
Amsterdam University Medical Center
Career Start Year 1989
Number of shared co-authors 0
The Institute of Cancer Research
Career Start Year 1988
Number of shared co-authors 5
Vrije Universiteit Amsterdam (VU)
Career Start Year 1987
Number of shared co-authors 1
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Career Start Year 1987
Number of shared co-authors 5
Neuroscience Institute, NYU Grossman School of Medicine
Career Start Year 1984
Number of shared co-authors 5
McDermott Center for Human Growth and Development.
Career Start Year 1984
Number of shared co-authors 3
Wellcome Sanger Institute
Career Start Year 1980
Number of shared co-authors 4
Broad Institute of MIT and Harvard
Career Start Year 1979
Number of shared co-authors 5

Collaborators

University of Toronto
Co-authored papers 68
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Co-authored papers 17
University of Toronto
Co-authored papers 15
Ontario Institute for Cancer Research, University Avenue
Co-authored papers 11
University of Toronto
Co-authored papers 8
Princess Margaret Cancer Research Centre
Co-authored papers 8
University of Toronto
Co-authored papers 6
Ontario Institute for Cancer Research, University Avenue
Co-authored papers 6
Lunenfeld-Tanenbaum Research Institute
Co-authored papers 5
Central China Normal University
Co-authored papers 5
Ontario Institute for Cancer Research, University Avenue
Co-authored papers 5
University of North Carolina School of Medicine
Co-authored papers 5
Lunenfeld-Tanenbaum Research Institute
Co-authored papers 4
University of Toronto, 1 Kings College Circle
Co-authored papers 4
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 4
UNC Chapel Hill School of Medicine
Co-authored papers 4
University of California los angeles
Co-authored papers 4
The Hospital for Sick Children, University of Toronto
Co-authored papers 4
Arthur and Sonia Labatt Brain Tumor Research Centre, Hospital for Sick Children
Co-authored papers 3
Institute for Research in Immunology and Cancer (IRIC), Universite de Montreal
Co-authored papers 3
The Hospital for Sick Children
Co-authored papers 3
International Research Center, A.C.Camargo Cancer Center
Co-authored papers 3
McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH)
Co-authored papers 3
Schroeder Arthritis Institute
Co-authored papers 3
The Hospital for Sick Children
Co-authored papers 3
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 3
College Street, University of Toronto
Co-authored papers 3
University of Toronto Toronto Ontario M5G 1L7 Canada.
Co-authored papers 3
The Hospital for Sick Children
Co-authored papers 3
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 3